Verona Pharma plc (I9SA F) stock market data APIs
€88.7231
-1.58(-1.8%)
as of July 11, 2025
Try our APIs with
free plan!
Verona Pharma plc Financial Data Overview
Price chart is built with
Anychart
Verona Pharma plc, a biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company offers Ohtuvayre, a dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that combines bronchodilator and non-steroidal anti-inflammatory effects for the maintenance treatment of chronic obstructive pulmonary disease, as well as cystic fibrosis and asthma. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.
Prev. Close
88.7231
Open
87.1456
High
88.7231
Low
87.1456
52 wk Range
16.4-91.6
Market Cap
10 314 M
Shares Outstanding
85 132 K
Revenue
119 M
EPS
-0.23
Beta
0.216
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Verona Pharma plc data using free add-ons & libraries
Get Verona Pharma plc Fundamental Data
Verona Pharma plc Fundamental data includes:
- Net Revenue: 119 M
- EBITDA: -133 641 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2022-11-09
- EPS/Forecast: -0.16
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Verona Pharma plc News
New
Biotech Stocks Are Ready to Rebound. 3 to Watch Now.
Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed strength. Large pharmaceutical companies, facing thinning pipelines, are aggre...
Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs.
The 200% figure lit up cable news chyrons, but investors focused instead on the grace period Trump floated. In a note titled “Tariffs Schmariffs,” Jefferies analyst Akash Tewari argues that if the...
Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Verona Pharma plc (NASDAQ:VRNA) is one of the stocks Jim Cramer recently discussed. Verona Pharma plc (NA...
Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck
Verona Pharma plc (NASDAQ:VRNA) is one of the 10 Stocks Going Wild. Verona Pharma surged by 20.62 percent on Wednesday to end at $104.77 per share following news that it was being acquired by US-bas...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
